Last reviewed · How we verify
NCT06918535: RCT
Progressive Muscle Relaxation Vs Muscle Energy Technique on Nonspecific Neck Pain in Prolonged Computer Users.
NA trial testing Progressive Muscle Relaxation Technique in Neck Pain in 60 participants. Currently enrolling.
15 April 2026
Quick facts
| Lead sponsor | IQRA University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 22 April 2025 |
| Primary completion | 15 April 2026 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Progressive Muscle Relaxation Technique
- Muscle Energy Technique
Conditions studied
- Neck Pain — all drugs for Neck Pain →
- Chronic Neck Pain — all drugs for Chronic Neck Pain →
Sponsor
IQRA University
Who can join
Adults 20 to 45, any sex, with Neck Pain or Chronic Neck Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this randomized controlled trial is to assess the potential effectiveness of Progressive muscle relaxation technique (PMRT) vs Muscle energy technique (MET) as an intervention for releasing trigger points in SCM and upper trapezius in prolonged computer users. The study will be conducted in a workplace setting, where desk-type computer users are expected to regularly engage in their professional activities for ≥ 6 hours throughout the day, intermittently. This study will be conducted at the Outpatient Physiotherapy department of Sindh Institute of Physical Medicine and Rehabilitation, Karachi among 60 patients with nonspecific chronic neck pain on the basis of non-probability purposive sample technique. After taking informed consent, all participants will be randomly allocated into two groups through a investigator (blinded) the same investigator will be screening the individuals, doing baseline assessment, and post treatment assessment while another investigator will be providing intervention. Group 1 will receive Progressive muscle relaxation technique while Group 2 will receive Muscle Energy Technique on sternocleidomastoid and upper trapezius bilaterally. Patients will also be blinded. A total of 12 sessions will be provided. Outcomes will be assessed at baseline and post treatment after 2 weeks intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06918535
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Progressive Muscle Relaxation Technique
Trials testing the same drug.
- NCT04051164 — Progressive Muscle Relaxation Technique on Lower Limb Amputation · NA · completed
Other recruiting trials for Neck Pain
Currently open trials in the same condition.
- NCT07163533 — Combined Effect of Kendall Exercises With Wearable Vibrotactile Feedback Sensor in Forward Head Posture · NA · recruiting
- NCT07332845 — Symmetrical Scapula-pelvis Proprioceptive Neuromuscular Facilitation and Superficial Back Line in Chronic Neck Pain With · NA · recruiting
- NCT07524075 — Effects of Muscle Energy Technique on Neck Disability and Cervical Range of Motion in Individuals With Non-Specific Neck · NA · recruiting
- NCT07292350 — Investigation of the Effects of a Neuromuscular Control-Focused Posture Training Program in Butchers · NA · recruiting
- NCT07290361 — Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06918535 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IQRA University
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06918535.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing